Clinical Trial

Normal Reference Range for Neonatal Echocardiography

Study acronym: NORRNE
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 16, 2024 (before its estimated December 30, 2024 completion). Its status may not reflect the trial's current state.
Summary
Echocardiography is the main method of bedside examination of neonatal cardiac morphology, which can timely diagnose congenital heart disease and quantitatively assess its severity, but the diagnosis and evaluation process depends on the normal range of neonatal echocardiography.At present, there have been normal reference standards for echocardiography in children and adults at home and abroad, but there is no uniform standard for echocardiographic parameters in newborns, especially premature infants.This study intends to carry out a national multicenter, prospective, observational study to establish the reference range of echocardiography at different time periods after birth in newborns, and stratified according to gestational age, birth weight and gender, to conduct a more accurate hemodynamic assessment of clinically critically ill newborns and guide the treatment of critically ill newborns in real time.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT05462301
Lead Sponsor Children's Hospital of Chongqing Medical University
Collaborators: Shanxi Provincial Maternity and Children's Hospital, Inner Mongolia Maternal and Child Health Care Hospital, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Ningxia Medical University
Conditions Echocardiography
Enrollment 1,500 participants
Start Date 2022-11-15
Primary Completion 2024-12-30 (estimated)
Study Completion 2024-12-30 (estimated)
Updated on ClinicalTrials.gov 2024-07-16